We are live on ! Find out more
EBS icon

Emergent Biosolutions
EBS

141 hedge funds and large institutions have $208M invested in Emergent Biosolutions in 2024 Q2 according to their latest regulatory filings, with 49 funds opening new positions, 35 increasing their positions, 36 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

126% more capital invested

Capital invested by funds: $91.6M → $208M (+$116M)

69% more first-time investments, than exits

New positions opened: 49 | Existing positions closed: 29

16% more funds holding

Funds holding: 122 → 141 (+19)

3% less repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 36

11.15% less ownership

Funds ownership: 69.21% → 58.06% (-11%)

47% less call options, than puts

Call options by funds: $3.09M | Put options by funds: $5.83M

Holders
141
Holders Change
+19
Holders Change %
+15.57%
% of All Funds
2.04%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
49
Increased
35
Reduced
36
Closed
29
Calls
$3.09M
Puts
$5.83M
Net Calls
-$2.74M
Net Calls Change
-$3.33M

Top Buyers

Rank Fund Capital Flow
1
American Century Companies
American Century Companies
Missouri
+$2.68M
2
CCM
Carronade Capital Management
Connecticut
+$2.37M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$1.77M
4
JP Morgan Chase
JP Morgan Chase
New York
+$1.62M
5
Jane Street
Jane Street
New York
+$1.58M

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$13.9M
2
APM
Avidity Partners Management
Texas
-$4.83M
3
Charles Schwab
Charles Schwab
California
-$4.24M
4
State Street
State Street
Massachusetts
-$3.7M
5
Renaissance Technologies
Renaissance Technologies
New York
-$3.09M
Name Holding Trade Value Shares
Change 		Change in
Stake
KLC
26
Kent Lake Capital
Nevada
$2.05M +$1.29M +300,000 New
Qube Research & Technologies (QRT)
27
Qube Research & Technologies (QRT)
United Kingdom
$1.87M +$1.18M +274,154 New
Federated Hermes
28
Federated Hermes
Pennsylvania
$1.86M +$1.09M +253,960 +1,314%
UBS Group
29
UBS Group
Switzerland
$1.75M -$125K -29,081 -10%
Dimensional Fund Advisors
30
Dimensional Fund Advisors
Texas
$1.64M -$609K -141,476 -37%
Squarepoint
31
Squarepoint
New York
$1.58M +$994K +231,014 New
Susquehanna International Group
32
Susquehanna International Group
Pennsylvania
$1.53M +$966K +224,503 New
State Street
33
State Street
Massachusetts
$1.35M -$3.7M -859,466 -81%
Los Angeles Capital Management
34
Los Angeles Capital Management
California
$1.22M -$65.2K -15,151 -8%
Renaissance Technologies
35
Renaissance Technologies
New York
$1.18M -$3.09M -717,553 -81%
HH
36
Hilltop Holdings
Texas
$1.08M -$206K -47,948 -23%
BCM
37
Bridgeway Capital Management
Texas
$1.04M -$1.89M -439,433 -74%
HT
38
Headlands Technologies
Illinois
$969K +$612K +142,155 New
Deutsche Bank
39
Deutsche Bank
Germany
$946K -$89.3K -20,752 -13%
New York State Common Retirement Fund
40
New York State Common Retirement Fund
New York
$939K -$67.4K -15,673 -10%
Truist Financial
41
Truist Financial
North Carolina
$897K +$61.8K +14,360 +12%
Cetera Investment Advisers
42
Cetera Investment Advisers
Illinois
$864K -$191K -44,320 -26%
HF
43
HRT Financial
New York
$854K +$539K +125,357 New
SWM
44
SeaCrest Wealth Management
New York
$784K +$81.7K +18,995 +20%
Fidelity Investments
45
Fidelity Investments
Massachusetts
$782K +$443K +103,041 +887%
Wellington Management Group
46
Wellington Management Group
Massachusetts
$777K +$491K +113,994 New
Acadian Asset Management
47
Acadian Asset Management
Massachusetts
$739K +$340K +79,028 +268%
Lazard Asset Management
48
Lazard Asset Management
New York
$691K +$437K +101,458 New
SFI
49
Susquehanna Fundamental Investments
Pennsylvania
$677K -$83.5K -19,393 -16%
Walleye Capital
50
Walleye Capital
New York
$659K +$282K +65,607 +212%
1
2
3 4 5

EBS Hedge Fund Activity: Q2 2024 in Review

141 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Emergent Biosolutions (EBS) for Q2 2024, worth a combined $208M — up 126% from $91.6M a quarter earlier.

Buyers outnumbered sellers: 49 funds opened new EBS positions and 29 closed out — a net gain of 20 holders — while 35 added to existing stakes and 36 trimmed.

The largest buyer was American Century Companies, adding an estimated $2.68M. The largest seller was BlackRock, cutting an estimated $13.9M.

  • 141 institutional investors held Emergent Biosolutions (EBS) as of Q2 2024, up from 122 in Q1 2024.
  • Funds reported $208M of Emergent Biosolutions stock for Q2 2024, up 126% quarter-over-quarter.
  • 49 funds opened new Emergent Biosolutions positions in Q2 2024 and 29 closed out, a net change of +20 holders.
  • The largest Emergent Biosolutions buyer in Q2 2024 was American Century Companies, an estimated $2.68M added.
  • The largest Emergent Biosolutions seller in Q2 2024 was BlackRock, an estimated $13.9M sold.

Based on aggregated 13F filings for Q2 2024.